How Much Did PathOtrak Raise?
Funding & Key Investors

PathOtrak has secured $2.8M in total funding, with its most recent financing round bringing in $2.2M. This major enterprise-level funding and strategic investment signal a significant phase of growth and market expansion for the foodborne pathogen detection specialist.

What is PathOtrak?

PathOtrak
Business ServicesResearch & DevelopmentHealthcare Services

PathOtrak is at the forefront of food safety technology, specializing in rapid foodborne pathogen detection. The company's innovative Next Generation Extraction (NGE) System delivers results in as little as two hours, a substantial improvement over traditional methods. This USDA and FDA-compliant technology is designed for critical industries including fresh produce, poultry, and beef, as well as environmental sampling. PathOtrak's solutions are engineered for cost-effectiveness, potentially reducing lab consumable expenses by up to 50%, positioning the company as a leader in efficient and reliable pathogen testing.

How much funding has PathOtrak raised?

PathOtrak has raised a total of $2.8M across 3 funding rounds:

2023

Other Financing Round

$300K

2024

Other Financing Round

$300K

2025

Debt

$2.2M

Other Financing Round (2023): $300K with participation from Tedco

Other Financing Round (2024): $300K led by Tedco

Debt (2025): $2.2M, investors not publicly disclosed

Key Investors in PathOtrak

Tedco

TEDCO, the Maryland Technology Development Corporation, is an organization focused on fostering economic growth through an inclusive entrepreneurial innovation ecosystem. They identify, invest in, and support technology and life science-based companies within Maryland.

Tedco

TEDCO, the Maryland Technology Development Corporation, plays a crucial role in empowering technological and life science ventures through strategic investment and ecosystem development.

What's next for PathOtrak?

The substantial enterprise-level capital infusion indicates PathOtrak is poised for significant scaling and market penetration. This strategic backing will likely fuel advancements in their NGE System, expand operational capacity, and broaden their reach across key food industry sectors. The company's focus on speed and cost reduction in pathogen detection aligns with increasing regulatory demands and consumer expectations for food safety, suggesting a trajectory towards becoming an indispensable partner for businesses prioritizing robust safety protocols.

See full PathOtrak company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesProject ManagementHealthcare SoftwareSoftware
Business ServicesCommercial PrintingAdvertising Networks
Business ServicesProject ManagementSoftware Testing
Business ServicesHuman Resources Management Systems (HRMS)

Frequently Asked Questions Regarding PathOtrak Financial Insights

What are the most recent funding rounds that PathOtrak has completed, and what were the funding rounds?
PathOtrak has recently completed 3 funding rounds: Debt on Sep 2, 2025, Other Financing Round on Feb 12, 2024, Other Financing Round on May 23, 2023.
What is the total amount of funding PathOtrak has raised to date?
PathOtrak has raised a total of $2.8M in funding to date.
How many funding rounds has PathOtrak completed?
PathOtrak has completed 3 funding rounds.
How much funding did PathOtrak raise in its most recent funding round?
PathOtrak raised $2.2M in its most recent funding round.
Which was the largest funding round in PathOtrak's history?
The largest funding round in PathOtrak's history was $2.2M.
See more information about PathOtrak